IMODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Imodium, and what generic alternatives are available?
Imodium is a drug marketed by J And J Consumer Inc and Janssen Pharms and is included in eight NDAs.
The generic ingredient in IMODIUM is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Imodium
A generic version of IMODIUM was approved as loperamide hydrochloride; simethicone by SUN PHARM INDS LTD on September 6th, 2006.
Summary for IMODIUM
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Clinical Trials: | 25 |
Patent Applications: | 3,501 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in IMODIUM? | IMODIUM excipients list |
DailyMed Link: | IMODIUM at DailyMed |
Recent Clinical Trials for IMODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Gilead Sciences | Phase 2 |
MedSIR | Phase 2 |
Naia Pharmaceuticals | Phase 1/Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for IMODIUM
US Patents and Regulatory Information for IMODIUM
Expired US Patents for IMODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
J And J Consumer Inc | IMODIUM | loperamide hydrochloride | CAPSULE;ORAL | 017694-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Janssen Pharms | IMODIUM | loperamide hydrochloride | SOLUTION;ORAL | 019037-001 | Jul 31, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for IMODIUM
See the table below for patents covering IMODIUM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Yugoslavia | 37330 | ⤷ Try a Trial | |
Netherlands | 173848 | ⤷ Try a Trial | |
Japan | S55120576 | 3*33DIARYLLTETRAHYDROO22FURYLIDENE AMMONIUM SALTS | ⤷ Try a Trial |
Netherlands | 7106829 | ⤷ Try a Trial | |
Japan | S55120577 | 3*33DIPHENYLLTETRAHYDROO22FURYLIDENE AMMONIUM SALTS | ⤷ Try a Trial |
Japan | S5754508 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for IMODIUM
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0428296 | SPC/GB98/013 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |